Biotech Investors' Loss Is Post's Creepy Gain

Author:
Publish date:
Updated on

Nuvelo Inc. top investors Wayne Holman of Ridgeback Capital and Wendy Commins of Ziff Brothers Investments lost a combined $125.6 million yesterday. Nuvelo dropped 80% yesterday when the company ceased trials on an experimental blood-thinning drug, due to failure to meet goals in two studies. The Post refers to Holman and Commins as "lovers" and imagines that the one "lover" (pronounced 'lov-ah') will likely say something along these lines to the other "lover," this evening:

Not tonight, honey. Really. Not tonight.

Maybe, maybe not. Poverty is, after all, one powerful aphrodisiac.
DOOM FOR 2: $125M: HEDGE HONEYS HIT [NY Post]

Related